Detection and follow-up of hepatic fibrosis in cystic fibrosis: a role for diagnostic liver biopsy and serum markers in evaluating outcomes of cystic fibrosis liver disease

被引：0
|
作者：
Walsh, M. J. [2 ]
Lewindon, P. J. [1 ,2 ]
Shepherd, R. W. [4 ]
Greer, R. M. [6 ]
Williamson, R. [3 ]
Pereira, T. N. [2 ]
Frawley, K.
Bell, S. [5 ]
Smith, J. L. [1 ]
Ramm, G. A. [2 ]
机构：
[1] Royal Childrens Hosp, Dept Gastroenterol, Brisbane, Qld, Australia
[2] Queensland Inst Med Res, Hepat Fibrosis Grp, Brisbane, Qld 4006, Australia
[3] Royal Brisbane Hosp, Dept Histopathol, Brisbane, Qld 4029, Australia
[4] Washington Univ, Sch Med, Dept Paediat, St Louis, MO USA
[5] Prince Charles Hosp, Dept Thorac Med, St Lucia, Qld, Australia
[6] Univ Queensland, Sch Vet Sci, St Lucia, Qld, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2009年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A225 / A225
页数：1
相关论文
共 50 条
  • [31] Management of liver disease in cystic fibrosis
    Badet, F
    ARCHIVES DE PEDIATRIE, 2003, 10 : 495S - 504S
  • [32] Liver disease in patients with cystic fibrosis
    Kamal, Natasha
    Surana, Pallavi
    Koh, Christopher
    CURRENT OPINION IN GASTROENTEROLOGY, 2018, 34 (03) : 146 - 151
  • [33] Outcome in Cystic Fibrosis Liver Disease
    Rowland, Marion
    Gallagher, Charles G.
    O'Laoide, Risteard
    Canny, Gerard
    Broderick, Annemarie
    Hayes, Roisin
    Greally, Peter
    Slattery, Dubhfeassa
    Daly, Leslie
    Durie, Peter
    Bourke, Billy
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (01): : 104 - 109
  • [34] The evolution of liver disease in cystic fibrosis
    Ling, SC
    Wilkinson, JD
    Hollman, AS
    McColl, J
    Evans, TJ
    Paton, JY
    ARCHIVES OF DISEASE IN CHILDHOOD, 1999, 81 (02) : 129 - 132
  • [35] Liver transplantation for hepatic cirrhosis in cystic fibrosis
    NobleJamieson, G
    Barnes, N
    Jamieson, N
    Friend, P
    Calne, R
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1996, 89 : 31 - 37
  • [36] Risk Factors for Hepatic Steatosis in Cystic Fibrosis Are Distinct from Risk Factors for Cystic Fibrosis Liver Disease
    Ayoub, Fares
    Lascano, Jorge
    Morelli, Giuseppe
    HEPATOLOGY, 2017, 66 : 663A - 664A
  • [37] The role of serum Pseudomonas aeruginosa antibodies in the diagnosis and follow-up of cystic fibrosis
    Dogru, Deniz
    Pekcan, Sevgi
    Yalcin, Ebru
    Ozcelik, Ugur
    Kiper, Nural
    Gurcan, Nermin
    Sener, Burcin
    TURKISH JOURNAL OF PEDIATRICS, 2013, 55 (01) : 50 - 57
  • [38] Evaluation of noninvasive markers for the diagnosis of cystic fibrosis liver disease
    Alexopoulou, Alexandra
    Pouriki, Sophia
    Vasilieva, Larisa
    Alexopoulos, Theodoros
    Filaditaki, Vasiliki
    Gioka, Maria
    Diamantea, Filia
    Dourakis, Spyros P.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2018, 53 (12) : 1547 - 1552
  • [39] LONG TERM FOLLOW-UP OF ADULT CYSTIC FIBROSIS PATIENTS: NONINVASIVE MARKERS PREDICT A SECOND WAVE OF LIVER DISEASE
    Koh, Christopher
    Chernick, Milica
    Zhao, Xiongce
    Eccleston, Jason
    Sakiani, Sasan
    Hoofnagle, Jay H.
    Heller, Theo
    HEPATOLOGY, 2010, 52 (04) : 905A - 905A
  • [40] Cystic Fibrosis Liver Disease: A Curious Case of Atypical Cystic Fibrosis Diagnosed in Adulthood
    Harriss, Patrick B.
    Jogimahanti, Anusha
    Herlevic, Vincent
    Samant, Hrishikesh
    Morris, James D.
    Jordan, Paul
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S1351 - S1351
12345